Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Abishek Vaidya, MS, Erin E Doherty, MD, Xiya Wu, Challice L. Bonifant, MD PhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD

Blood (2019) 134 (Supplement_1): 4441.

https://doi.org/10.1182/blood-2019-125395

Published: 2019

Journal Articles

Acute Common Iliac Artery Thrombosis with Concurrent Pulmonary Embolism Revealing AML M2: Role of Elevated Plasma Tissue Factor Activity

Hind Bennani, PharmD, Raphaël Coscas, MD, Marc Coggia, MD, Patrick Van Dreden, PhD, Marc Vasse, PharmD, Jacques Vargaftig, MD

Blood (2015) 126 (23): 4722.

https://doi.org/10.1182/blood.V126.23.4722.4722

Published: 2015

Journal Articles

CITED2 Cooperates with Low PU.1 and DNMT3A to Maintain Self-Renewal in Hematopoietic Stem Cells

Hein Schepers, PhD, Patrick Korthuis, MSc, Marjan Geugien, MSc, Jennifer Jaques, MSc, Tihomira I. Todorova, MSc, Ulrich Steidl, MD PhD, Jan Jacob Schuringa, PhD, Edo Vellenga, MD PhD

Blood (2015) 126 (23): 309.

https://doi.org/10.1182/blood.V126.23.309.309

Published: 2015

Journal Articles

Economic Burden of Adverse Events Among Patients with Chronic Myelogenous Leukemia Treated with BCR-ABL1 Tyrosine Kinase Inhibitors

Jay Lin, PhD MBA, Makenbaeva Dinara, MD MBA, Bilmes Robyn, PharmD, BCOP, Melissa Lingohr-Smith, PhD, Nicola Wallis, MRCPath, FFPM

Blood (2015) 126 (23): 876.

https://doi.org/10.1182/blood.V126.23.876.876

Published: 2015

Journal Articles

The Effect of the R882H DNMT3a Mutation on Megakaryocyte Cell Lines

Yang Lu, MD, Dan Wang, Yifang Yuan, Li mei Chen, Yi ke Huang, Hao Huang, MD, Kefeng Shen, MD, Yanyan Ye, Jing Sun, MD, Qianli Jiang, MD PhD

Blood (2014) 124 (21): 5186.

https://doi.org/10.1182/blood.V124.21.5186.5186

Published: 2014

Journal Articles

Peripheral Arterial Occlusive Disease (PAOD) In Patients (Pts) Receiving Dasatinib: Experience Across Multiple Clinical Trials

Philipp D. le Coutre, MD, Timothy P. Hughes, MD, MBBS, Francois-Xavier Mahon, Dong-Wook Kim, Juan Luis Steegmann, Neil P. Shah, MD, PhD, Nicola Wallis, Jorge E. Cortes, MD

Blood (2013) 122 (21): 1489.

https://doi.org/10.1182/blood.V122.21.1489.1489

Published: 2013

Journal Articles

CITED2 Modulates Differentiation and Proliferation of Normal and Leukemic Hematopoietic Stem and Progenitor Cells Downstream of PU.1

Hein Schepers, Ph.D, Patrick M. Korthuis, Jan J. Schuringa, PhD, Gerald de Haan, Ph.D, Edo Vellenga, PhD

Blood (2011) 118 (21): 922.

https://doi.org/10.1182/blood.V118.21.922.922

Published: 2011

Journal Articles

Retrospective Cohort Analysis of Peripheral Arterial Occlusive Disease (PAOD) Events in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Francis J. Giles, MB, MD, FRCPI, FRCPath, Michael J. Mauro, MD, Frank Hong, MD, PhD, MPH, Christine-Elke Ortmann, Richard C. Woodman, Philipp D. LeCoutre, MD, Giuseppe Saglio, MD

Blood (2011) 118 (21): 2757.

https://doi.org/10.1182/blood.V118.21.2757.2757

Published: 2011

Journal Articles

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Tetsuya Tanimoto, MD, Yasuo Oshima, MD, PhD, FACP, Koichiro Yuji, M.D., Ph.D., Masahiro Kami, MD, PhD

Blood (2011) 118 (21): 1698.

https://doi.org/10.1182/blood.V118.21.1698.1698

Published: 2011

Journal Articles

Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes

Concetta Quintarelli, Juan F. Vera, Barbara Savoldo, Greta M. P. Giordano Attianese, Martin Pule, Aaron E. Foster, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, Gianpietro Dotti

Blood (2007) 110 (8): 2793–2802.

https://doi.org/10.1182/blood-2007-02-072843

Published: 2007

Includes: Supplemental data

NARROW

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Acute Common Iliac Artery Thrombosis with Concurrent Pulmonary Embolism Revealing AML M2: Role of Elevated Plasma Tissue Factor Activity

CITED2 Cooperates with Low PU.1 and DNMT3A to Maintain Self-Renewal in Hematopoietic Stem Cells

Economic Burden of Adverse Events Among Patients with Chronic Myelogenous Leukemia Treated with BCR-ABL1 Tyrosine Kinase Inhibitors

The Effect of the R882H DNMT3a Mutation on Megakaryocyte Cell Lines

Peripheral Arterial Occlusive Disease (PAOD) In Patients (Pts) Receiving Dasatinib: Experience Across Multiple Clinical Trials

CITED2 Modulates Differentiation and Proliferation of Normal and Leukemic Hematopoietic Stem and Progenitor Cells Downstream of PU.1

Retrospective Cohort Analysis of Peripheral Arterial Occlusive Disease (PAOD) Events in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only